These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23143758)

  • 1. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
    Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
    Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A; Kao LY; Liu L; Wang NK
    BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is intravitreal topotecan toxic to retinal function?
    Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
    Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
    De Francesco S; Galluzzi P; Bracco S; Menicacci F; Motolese E; Hadjistilianou T
    Int Ophthalmol; 2015 Dec; 35(6):887-95. PubMed ID: 26416040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F; Amoli FA
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç İ; Varan A; Akyüz C
    Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.
    Abramson DH; Ji X; Francis JH; Catalanotti F; Brodie SE; Habib L
    Br J Ophthalmol; 2019 Apr; 103(4):488-493. PubMed ID: 29875233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
    Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
    Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
    Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL
    J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.